Description
PrymaLab · Research Use Only
Retatrutide 50mg
LY3437943 · extended supply · 39 residues
Retatrutide 50mg is an extended supply lyophilized vial of LY3437943, CAS 2381089-83-2, approximately 10.2 micromoles. At this quantity most of the material will spend time in storage rather than in an experiment, which makes stability the governing consideration.
Specification Table
| Property | Value |
|---|---|
| Compound | Retatrutide |
| Development code | LY3437943 |
| CAS number | 2381089-83-2 |
| Vial content | 50 mg lyophilized powder |
| Molar content at MW 4894.58 | Approximately 10.2 µmol |
| Aggregation driver | The C20 diacid conjugate provides a hydrophobic nucleation point |
| Molecular formula | C228H350N48O66 |
| Molecular weight | Contested. 4894.58 and 4731.33 both circulate. See the note on the 5mg page |
| Residue count | 39 |
| C-terminus | Amidated |
| Peptide backbone | Based on the GIP sequence rather than GLP-1 |
| Non-coded residue, position 2 | α-aminoisobutyric acid (Aib) |
| Non-coded residue, position 13 | α-methyl-leucine |
| Non-coded residue, position 20 | α-aminoisobutyric acid (Aib) |
| Lipid conjugation | Lysine 17 side chain bears PEG2-γ-Glu-eicosanedioic acid |
| Molecular targets | GIP receptor, GLP-1 receptor, glucagon receptor |
| Reported EC50, GIPR | 0.0643 nM |
| Reported EC50, GLP-1R | 0.775 nM |
| Reported EC50, GCGR | 5.79 nM |
| Originating organisation | Eli Lilly |
| Appearance | White lyophilized powder |
| Purity | Per lot-specific certificate of analysis |
| Solubility | Water soluble. Slightly alkaline buffer aids dissolution |
| Storage, lyophilized | -20°C, protected from light and moisture |
| Storage, reconstituted | 2-8°C, protected from light |
| Regulatory status | Investigational. No approved formulation in any jurisdiction |
What Drives Retatrutide Aggregation?
Retatrutide 50mg aggregates by a mechanism that unmodified sequences of the same length do not have available, and understanding it explains most of the handling guidance.
A peptide chain carrying a twenty-carbon hydrocarbon tail is amphipathic by construction. In aqueous solution the hydrophobic tail is energetically unfavourable exposed to water, and the cheapest way to bury it is against another molecule tail.
That association is concentration-dependent and cooperative. Below a threshold the molecules stay largely monomeric. Above it they assemble, and the assembly grows because each added molecule buries more hydrophobic surface.
The assemblies that form range from small reversible micelle-like clusters to extended fibrillar structures. The reversible end is tolerable, while the fibrillar end is not, because peptide within a fibril is conformationally locked and no longer available to bind anything.
Helical character compounds it. The Aib substitutions that pre-organise the chain toward a helix also favour the intermolecular packing that stabilises fibrils, so the same modification improving receptor binding raises aggregation propensity.
The practical rule that follows is counterintuitive: for storage, dilute beats concentrated. Most peptide guidance says the opposite because most peptides do not have a lipid tail.
What Is Retatrutide Solution Stability in Practice?
Time in solution is the variable that most reliably degrades Retatrutide 50mg, and the degradation is physical rather than chemical.
Chemical degradation is comparatively slow, since there is no cysteine and one methionine at most to oxidise, and the terminal amide plus the Aib substitutions block the fastest enzymatic and hydrolytic routes.
Physical degradation is fast by comparison. Aggregation proceeds continuously in solution at a rate set by concentration, temperature and agitation history, and it does not reverse on dilution once fibrils have formed.
That asymmetry means a stability assessment based on mass spectrometry alone will look reassuring while the material is quietly becoming unusable. Mass is unchanged by aggregation; only the physical state changes.
Size-exclusion chromatography is the measurement that sees it, because it separates by hydrodynamic radius rather than mass. Dynamic light scattering serves the same purpose and needs less material.
For a working stock the practical horizon is days to a few weeks at 2 to 8 degrees, shorter at higher concentration. Frozen aliquots extend that window considerably, provided each is thawed only once.
How Should Retatrutide Cold Chain Be Handled?
Shipping and receiving conditions matter more for a lipidated peptide than the lyophilized state alone would suggest, and the reasons are worth stating.
In the dry state this compound is hard to damage. Lyophilized material tolerates ambient temperature for the durations typical of shipping without meaningful loss, which is why dry powder is the format of choice for transport.
What matters on receipt is condensation. A cold package opened in a warm humid room deposits water onto hygroscopic powder, and once local moisture is present the material is no longer in the dry state that made it stable.
Allow sealed vials to equilibrate to room temperature before opening. This single step averts more degradation than any other handling instruction on this page.
Record any temperature excursion in transit with its duration. For dry material a brief excursion is usually inconsequential, but the record is what allows that judgment to be made rather than assumed.
Store at -20°C on receipt, sealed against light and moisture. Repeated removal from cold storage for weighing accumulates condensation exposure, which argues for dividing the vial once rather than returning to it repeatedly.
What Does the Extended Supply Format Suit?
Retatrutide 50mg is a programme-scale quantity, and the arguments for and against it are specific.
Lot continuity is the strongest argument. This synthesis involves three non-coded residues and a three-part conjugate, so the proportion of fully modified product varies between runs and a single lot holds that constant across a whole body of work.
Throughput is the second. Animal work consumes material at rates that make repeated small purchases impractical and that would otherwise force a lot change mid-study for supply reasons rather than design reasons.
Against both, a large vial invites bulk reconstitution, and bulk reconstitution is exactly what the aggregation section argues against. The format is only advantageous if the material is divided dry or aliquoted immediately.
A vial that sits half-used in solution for months is worse than several smaller vials used promptly, and that is a realistic failure mode rather than a theoretical one.
The decision therefore turns on whether the laboratory has the discipline and the balance to divide dry powder accurately. Where it does, this format is the better purchase.
What Should Guide Buying Retatrutide Online?
The search term is commercial and the honest answer is a set of criteria rather than a recommendation.
Documentation is the primary discriminator, and the seven certificate fields listed on the 40mg page are the test. A supplier producing all seven has characterised their material analytically.
Storage and shipping conditions stated explicitly, including whether material ships with a cold pack and what the transit temperature record shows. For dry powder this matters less than for solutions, and a supplier who understands that distinction is demonstrating competence.
CAS 2381089-83-2 present on the paperwork, with a measured mass rather than a catalogue figure given the discrepancy documented across this ladder.
Willingness to answer specific questions about the lipid conjugation and the non-coded residues. Those are the two things most likely to be wrong and the two things a reseller will not know.
Price is the weakest signal and it tracks documentation more closely than it tracks anything else in this compound class.
What Does Retatrutide 50mg Change About Handling?
Ten point two micromoles shifts the governing question from how to use the material to how to hold it.
For smaller fills most of the vial passes through experiments quickly. With Retatrutide 50mg most of it waits, and waiting is where a lipidated peptide degrades.
The dry state is stable and the solution state is not, so the handling decision that matters is how much gets reconstituted and when. Retatrutide 50mg rewards dividing the powder and penalises bulk reconstitution.
Storage temperature is secondary to storage state. Material held dry at minus 20 outlasts material held cold in solution by a wide margin.
Where dry division is impractical, aliquoting immediately after reconstitution and freezing recovers most of the advantage.
How Should 50mg Be Divided and Recorded?
With Retatrutide 50mg, divide dry where possible and reconstitute only what will be used, and hold the remainder in the stable state.
Weighing lyophilized peptide accurately requires an analytical balance and attention to static, which fine powder attracts readily. An anti-static device or grounded weighing vessel makes the difference between a defensible weight and an approximate one.
Where full reconstitution is preferred, 10 ml gives roughly 1.02 mM and holds the ladder arithmetic consistent across every format in this range.
Aliquot into single-use volumes immediately and freeze. Inspect each aliquot for clarity on thawing rather than assuming, since aggregated material fails silently and is not recoverable.
Use low-binding plastic at every step. A carrier protein helps recovery where the assay allows one, with the caveat that albumin binds the conjugate and moves the free fraction as it does so.
Record lot, verification results, the molecular weight used, mass weighed, diluent, volume, measured concentration, aliquot scheme, freeze-thaw count per aliquot, and every date. At this scale the record is what connects a late anomaly to the material that produced it.
A final note on detecting trouble early. Because aggregation is silent to mass spectrometry, a laboratory relying on mass alone will not see it until an assay result goes strange.
Running dynamic light scattering once on a fresh aliquot establishes a baseline, and repeating it later answers the question directly rather than by inference.
It needs a few microlitres and about ten minutes, which is a small price for knowing whether a stock is still monomeric.
A last note on agitation during transport. Vials shipped dry tolerate handling well, but material already in solution and shipped cold accumulates interface exposure with every jolt.
That is one more argument for buying lyophilized and reconstituting on arrival rather than sourcing a solution product for a lipidated peptide.
One more consideration for long programmes. Aggregation propensity is a property of the lot as well as the molecule, since residual synthesis impurities can seed assembly.
A lot that behaves well in the first month is likely to keep behaving well, and one that shows early haze will not improve. Early observation is therefore predictive rather than merely descriptive.
Published Literature
References verified against the publisher record. Aggregation guidance reflects general lipidated-peptide behaviour rather than findings specific to the published pharmacology.
- Coskun T, Urva S, Roell WC, Qu H, Loghin C, Moyers JS, O’Farrell LS, Briere DA, Sloop KW, Thomas MK, Pirro V, Wainscott DB, Willard FS, Abernathy M, Morford L, Du Y, Benson C, Gimeno RE, Haupt A, Coskun T. Cell Metabolism. 2022;34(9):1234-1247.
- Urva S, Coskun T, Neff LM, Yeo KP, Loghin C, Ma X, Landry J, Bray R, Milicevic Z, Haupt A. The Lancet. 2022;400(10366):1869-1881.
- Jastreboff AM, Kaplan LM, Frias JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML. New England Journal of Medicine. 2023;389(6):514-526.
- Willard FS, Douros JD, Gabe MB, Showalter AD, Wainscott DB, Suter TM, Capozzi ME, van der Velden WJ, Stutsman C, Cardona GR, et al. JCI Insight. 2020;5(17):e140532.
- Finan B, Yang B, Ottaway N, Smiley DL, Ma T, Clemmensen C, Chabenne J, Zhang L, Habegger KM, Fischer K, et al. Nature Medicine. 2015;21(1):27-36.
Frequently Asked Questions
What is Retatrutide 50mg?
An extended supply lyophilized vial of LY3437943, CAS 2381089-83-2, approximately 10.2 micromoles. At this quantity most material spends time in storage rather than in an experiment, which makes stability the governing consideration.
Why do lipidated peptides aggregate?
Because a twenty-carbon hydrocarbon tail is energetically unfavourable exposed to water, and the cheapest way to bury it is against another molecule tail. That association is concentration-dependent and cooperative.
Is the aggregation reversible?
Partly. Small micelle-like clusters are reversible and tolerable, while extended fibrillar structures are not, since peptide locked inside a fibril is no longer available to bind anything at all.
Do the Aib substitutions make it worse?
Yes, somewhat. The same helical pre-organisation that improves receptor binding also favours the intermolecular packing that stabilises fibrils, so the modification cuts both ways.
What is the counterintuitive storage rule?
For storage, dilute beats concentrated. Most peptide guidance says the opposite because most peptides lack a lipid tail, and aggregation here is strongly concentration-dependent.
Which degrades faster, chemistry or physics?
Physics, by a wide margin. There is no cysteine and the terminal amide plus Aib substitutions block the fastest chemical routes, while aggregation proceeds continuously and does not reverse once fibrils form.
Why is mass spectrometry reassuring but misleading here?
Because aggregation does not change mass, only physical state. A stability assessment based on mass alone will look fine while the material becomes unusable.
What measurement sees aggregation?
Size-exclusion chromatography, which separates by hydrodynamic radius rather than mass. Dynamic light scattering serves the same purpose and needs considerably less material.
How should a cold shipment be received?
By allowing sealed vials to equilibrate to room temperature before opening. A cold package opened in a warm humid room deposits water onto hygroscopic powder, and heading that off does more good than any other single step.
Is a transit temperature excursion serious?
For dry powder, usually not. Lyophilized material tolerates ambient temperature for typical shipping durations. The record still matters, because it lets that judgment be made rather than assumed.
When is the extended format the wrong choice?
When the laboratory will reconstitute in bulk and leave the vial half-used in solution for months. Several smaller vials used promptly beat one large vial held in solution, and that is a realistic failure mode.
Compliance Statement
Retatrutide 50mg is sold exclusively for laboratory research use. It is not a drug, food, or cosmetic product, and it is not a dietary product of any kind. It is not approved by the FDA or any comparable authority for human or veterinary use, it is an investigational compound with no approved formulation in any jurisdiction, and material supplied as a research chemical is not a clinical product. This product is not intended to diagnose, treat, cure, or prevent any disease. It must not be given to humans or animals. Purchase is restricted to qualified researchers and institutions operating within applicable laws. All handling is the responsibility of the purchasing laboratory.
18 reviews for Retatrutide 50mg